Us Bancorp \De\ Avidity Biosciences, Inc. Transaction History

Us Bancorp \De\

$74.1 Billion
Q1 2025

A detailed history of Us Bancorp \De\ transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 5,468 shares of RNA stock, worth $176,507. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,468

Previous 6,568 16.75%

Holding current value

$176,507

Previous $190,000 15.26%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 08, 2025	SELL	$27.05 - $35.11 $29,755 - $38,621	-1,100 Reduced 16.75%	5,468 $161,000
Q4 2024 Feb 05, 2025	BUY	$29.08 - $52.5 $38,501 - $69,510	1,324 Added 25.25%	6,568 $190,000
Q3 2024 Oct 28, 2024	SELL	$37.21 - $48.14 $1.98 Million - $2.56 Million	-53,154 Reduced 91.02%	5,244 $240,000
Q2 2024 Aug 06, 2024	SELL	$22.73 - $40.85 $84,237 - $151,390	-3,706 Reduced 5.97%	58,398 $2.39 Million
Q1 2024 May 07, 2024	BUY	$9.16 - $25.52 $1,282 - $3,572	140 Added 0.23%	62,104 $1.58 Million
Q4 2023 Feb 09, 2024	BUY	$4.87 - $9.37 $7,290 - $14,026	1,497 Added 2.48%	61,964 $560,000
Q3 2023 Nov 03, 2023	BUY	$6.3 - $11.35 $12,222 - $22,019	1,940 Added 3.31%	60,467 $385,000
Q2 2023 Aug 09, 2023	BUY	$10.62 - $17.34 $13,859 - $22,628	1,305 Added 2.28%	58,527 $649,000
Q1 2023 May 09, 2023	SELL	$15.35 - $25.65 $300,246 - $501,714	-19,560 Reduced 25.47%	57,222 $878,000
Q4 2022 Feb 13, 2023	BUY	$10.06 - $22.66 $13,279 - $29,911	1,320 Added 1.75%	76,782 $1.7 Million
Q3 2022 Oct 27, 2022	SELL	$15.46 - $23.43 $778,720 - $1.18 Million	-50,370 Reduced 40.03%	75,462 $1.23 Million
Q2 2022 Aug 01, 2022	BUY	$11.18 - $20.5 $635,750 - $1.17 Million	56,865 Added 82.45%	125,832 $1.83 Million
Q1 2022 May 11, 2022	SELL	$14.2 - $23.78 $980,382 - $1.64 Million	-69,041 Reduced 50.03%	68,967 $1.27 Million
Q4 2021 Feb 11, 2022	SELL	$20.4 - $28.66 $2.41 Million - $3.39 Million	-118,260 Reduced 46.15%	138,008 $3.28 Million
Q3 2021 Nov 10, 2021	BUY	$18.16 - $25.21 $4.63 Million - $6.43 Million	254,868 Added 18204.86%	256,268 $6.31 Million
Q1 2021 Apr 28, 2021	BUY	$20.28 - $28.15 $28,392 - $39,410	1,400 New	1,400 $31,000

Others Institutions Holding RNA

# of Institutions

256

Shares Held

101M

Call Options Held

517K

Put Options Held

717K

View Full List

About Avidity Biosciences, Inc.

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $1.68B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

More about RNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account